← All companies
RXRX annual revenue
RECURSION PHARMACEUTICALS, INC.
RXRX - CIK 0001601830
Market cap$1.61 B
Rank#2257
SEC filings908
RECURSION PHARMACEUTICALS, INC. revenue by year
RECURSION PHARMACEUTICALS, INC. (RXRX) reported revenue of $74.68M for fiscal year 2025, as filed in its audited annual report with the SEC.
RXRX revenue 2019-2025
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $74.68M | +26.9% |
| FY 2024 | $58.84M | +32.0% |
| FY 2023 | $44.58M | +11.9% |
| FY 2022 | $39.84M | +291.5% |
| FY 2021 | $10.18M | +156.9% |
| FY 2020 | $3.96M | +70.8% |
| FY 2019 | $2.32M | - |
Revenue of similar companies
Frequently asked questions
How much revenue does RECURSION PHARMACEUTICALS, INC. make?
RECURSION PHARMACEUTICALS, INC. (RXRX) reported revenue of $74.68M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has RECURSION PHARMACEUTICALS, INC.'s revenue changed over time?
Between fiscal 2019 and fiscal 2025, RECURSION PHARMACEUTICALS, INC.'s revenue grew from $2.32M to $74.68M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.